Lipopolysaccharides from Helicobacter pylori can act as antagonists for Toll-like receptor 4

被引:86
|
作者
Lepper, PM
Triantafilou, M
Schumann, C
Schneider, EM
Triantafilou, K [1 ]
机构
[1] Univ Sussex, Sch Life Sci, Infect & Immun Grp, Brighton BN1 9QG, E Sussex, England
[2] Univ Ulm, Dept Med Microbiol & Hyg, D-89075 Ulm, Germany
[3] Univ Ulm, Dept Internal Med 2, D-89075 Ulm, Germany
[4] Univ Ulm, Sect Expt Anaesthesiol, D-89075 Ulm, Germany
关键词
D O I
10.1111/j.1462-5822.2005.00482.x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Infection with Helicobacter pylori, a Gram-negative bacterium, is strongly associated with gastric ulcers and adenocarcinoma. The mechanisms by which the innate immune system recognizes H. pylori lipopolysaccharide (LPS) remain unclear. Contradictory reports exist that suggest that Toll-like receptors are involved. In this study we evaluated the interactions of Toll-like receptors with LPS from different strains of H. pylori. Using reporter cell lines, as well as HEK293 cells transfected with either CD14 and TLR4, or CD14 and TLR2, we show that H. pylori LPS-induced cell activation is mediated through TLR2. In addition, for the first time, we report that LPS from some H. pylori strains are able to antagonize TLR4. The antagonistic activity of H. pylori LPS from certain strains, as well as the activation via TLR2, might give H. pylori an advantage over the host that may be associated with the clinical outcome of H. pylori infection.
引用
收藏
页码:519 / 528
页数:10
相关论文
共 50 条
  • [41] Lipopolysaccharides from Helicobacter pylori NCTC11637 up-regulate IL-8 and VEGF via toll-like receptor 2 in an epithelial cell system
    Smith, Sinead
    Moran, Anthony P.
    Kelleher, Dermot P.
    GASTROENTEROLOGY, 2006, 130 (04) : A526 - A526
  • [42] Therapeutic targeting of innate immunity with Toll-like receptor 4 (TLR4) antagonists
    Peri, Francesco
    Piazza, Matteo
    BIOTECHNOLOGY ADVANCES, 2012, 30 (01) : 251 - 260
  • [43] The toll-like receptor signaling pathway in host cells is affected by Helicobacter pylori pldA phase variation
    Vollan, H. S.
    Esbensen, Y.
    Tannaes, T.
    Bukholm, G.
    HELICOBACTER, 2006, 11 (04) : 346 - 347
  • [44] Toll-like receptor 4 (TLR4) antagonists as potential therapeutics for intestinal inflammation
    Tam, Janine S. Y.
    Coller, Janet K.
    Hughes, Patrick A.
    Prestidge, Clive A.
    Bowen, Joanne M.
    INDIAN JOURNAL OF GASTROENTEROLOGY, 2021, 40 (01) : 5 - 21
  • [45] Genetic polymorphisms in the Toll-like receptor signalling pathway in Helicobacter pylori infection and related gastric cancer
    Castano-Rodriguez, Natalia
    Kaakoush, Nadeem O.
    Pardo, Aryce L.
    Goh, Khean-Lee
    Fock, Kwong Ming
    Mitchell, Hazel M.
    HUMAN IMMUNOLOGY, 2014, 75 (08) : 808 - 815
  • [46] Toll-like receptor 4 (TLR4) antagonists as potential therapeutics for intestinal inflammation
    Janine S. Y. Tam
    Janet K. Coller
    Patrick A. Hughes
    Clive A. Prestidge
    Joanne M. Bowen
    Indian Journal of Gastroenterology, 2021, 40 : 5 - 21
  • [47] Macrophages recognize the Helicobacter pylori type IV secretion system in the absence of toll-like receptor signalling
    Koch, Manuel
    Mollenkopf, Hans-Joachim
    Meyer, Thomas F.
    CELLULAR MICROBIOLOGY, 2016, 18 (01) : 137 - 147
  • [49] Lactabacilli inhibit interleukin-8 production induced by Helicobacter pylori lipopolysaccharide-activated Toll-like receptor 4
    Zhou, Chao
    Ma, Feng-Zhen
    Deng, Xue-Jie
    Yuan, Hong
    Ma, Hong-Sheng
    WORLD JOURNAL OF GASTROENTEROLOGY, 2008, 14 (32) : 5090 - 5095
  • [50] Toll-like receptor-dependent activation of dendritic cells affects adaptive immunity to Helicobacter pylori
    Rad, Roland
    Brenner, Lena
    Schmid, Roland M.
    Prinz, Christian
    GASTROENTEROLOGY, 2007, 132 (04) : A219 - A220